TY  - GEN
AU  - Abrunhosa-Branquinho,André N
AU  - Bar-Deroma,Raquel
AU  - Collette,Sandra
AU  - Clementel,Enrico
AU  - Liu,Yan
AU  - Hurkmans,Coen W
AU  - Feuvret,Loïc
AU  - Van Beek,Karen
AU  - van den Bent,Martin
AU  - Baumert,Brigitta G
AU  - Weber,Damien C
TI  - Radiotherapy quality assurance for the RTOG 0834/EORTC 26053-22054/NCIC CTG CEC.1/CATNON intergroup trial "concurrent and adjuvant temozolomide chemotherapy in newly diagnosed non-1p/19q deleted anaplastic glioma": Individual case review analysis
SN  - 1879-0887
PY  - 2018///1109
KW  - Antineoplastic Agents, Alkylating
KW  - therapeutic use
KW  - Brain Neoplasms
KW  - drug therapy
KW  - Chemotherapy, Adjuvant
KW  - Chromosome Deletion
KW  - Chromosomes, Human, Pair 1
KW  - Chromosomes, Human, Pair 19
KW  - Dacarbazine
KW  - analogs & derivatives
KW  - Glioma
KW  - Humans
KW  - Prospective Studies
KW  - Quality Assurance, Health Care
KW  - Radiotherapy Planning, Computer-Assisted
KW  - methods
KW  - Retrospective Studies
KW  - Temozolomide
KW  - Tomography, X-Ray Computed
N1  - Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1016/j.radonc.2018.03.013
ER  -